Increasing incidence of multiple sclerosis in women in Northern Finland

Multiple Sclerosis Journal

Volumn 17, Issue 2, 2011, Pages 133-138

  Krokki O ^a   Bloigu, R ^a   Reunanen, M ^a   Remes, A M ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

incidence; multiple sclerosis; prevalence; sex differences

Indexed keywords

ADULT; AGED; ARTICLE; EPIDEMIOLOGICAL DATA; FEMALE; FINLAND; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; RETROSPECTIVE STUDY; SEX RATIO;

EID: 79951539087     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510384012     Document Type: Article

References (26)

1. Munger KL, Levin LI, Hollis BW, Howard NS and Ascherio A. Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA 2006 ; 23: 2832-2838. (Pubitemid 44969183)
2. Kurtzke JF A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 1975 ; 51: 110-136.
3. Holick MF Vitamin D Defiency. N Engl J Med 2007 ; 357: 266-268.
4. Grey OM, McDonell GV and Hawkins SA Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Multiple Sclerosis 2008 ; 14: 880-886.
5. Dahl OP, Aarseth JH, Myhr KM, Nyland H. and Midgard R. Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 2004 ; 109: 378-384. (Pubitemid 38698173)
6. Barnett MH, Williams DB, Day S., Macaskill P. and McLeod JG Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 2003 ; 213: 1-6. (Pubitemid 36842857)
7. Noonan CW, Williamson DM, Henry JP, Indian R., Lynh SG, Neuberger JS, et al. The Prevalence of Multiple Sclerosis in 3 US Communities. Prev Chronic Dis 2010 ; 1: 1-8.
8. Saadatnia M., Etemadifar M. and Maghzi AH Multiple sclerosis in Istahan, Iran. Int Rev Neurobiol 2007 ; 79: 357-375.
9. Houzen H., Niino M., Hata D., Nakano F., Kikuchi S., Fukazawa T., et al. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008 ; 14: 887-892.
10. Hirst C., Ingram G., Pickersgill T., Swingler R., Copston DAS and Robertson NP Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009 ; 80: 386-391.
11. Maghzi AH, Ghazavi H., Ahsan M., Etemadifar M., Mousavi SA, Khorvash F., et al. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 2010 ; 16: 359-361.
12. Orton S. -M, Herrera BM, Yee IM, Valdar W., Ramagopalan SV, Sadovnic SV, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006 ; 5: 932-936. (Pubitemid 44556546)
13. Orton S. -M, Ramagopalan SV, Brocklebank D., Herrera BM, Dyment DA, Yee IM, et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadan collaborative study. J Neurol Neurosurg Psychiatry 2010 ; 81: 31-37.
14. Sumelahti M-L., Tienari PJ, Wikström J., Palo J. and Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001 ; 103: 153-158. (Pubitemid 32158438)
15. Sumelahti M-L., Tienari PJ, Wikström J. and Palo J. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology 2000 ; 19: 67-75. (Pubitemid 30111735)
16. Poser CM, Paty DW, Scheinberg L., McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231. (Pubitemid 13158528)
17. McDonald WI, Compston A., Edan G., Goodgin D., Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
18. Polman CH, Reingold SC, Edan G., Filippi M., Hartung HP, Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol 2005 ; 58: 840-846. (Pubitemid 41746873)
19. Altman DG, Machin D., Bryant TN and Gardner MJ Statistics with Confidence, 2 nd edition. London: BMJ Books, 2000.
20. Ruth AM Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004 ; 3: 709-718.
21. Sarasoja T., Wikström J., Paltamaa J., Hakamaa M. and Sumelahti M-L. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 2004 ; 110: 331-336. (Pubitemid 39423051)
22. Wikström J. and Palo J. Studies on clustering of multiple sclerosis in Finland II: the microepidemiology in one high-risk county with special reference to familial cases. Acta Neurol Scand 1975 ; 51: 173-183.
23. Sundström P., Nyström L. and Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten Country in northern Sweden. J Neurol Neurosurg Psychiatry 2003 ; 74: 29-32. (Pubitemid 36069032)
24. Kragt JJ, van Amerongen BM, Killestein J., Dijkstra CD, Uitdehaag BMJ and Polman CH Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009 ; 15: 9-15.
25. Spach KM and Hayes CE Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005 ; 175: 4119-4126. (Pubitemid 41292076)
26. Paturi M., Tapanainen H., Reinivuo H. and Pietinen P. The National FINDIET 2007 Survey. Helsinki: KTL-National Public Health Institute, Department of Health Promotion and Chronic Disease Prevention, Nutrition Unit, 2008, pp. 69-70.